Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Krystal (KRYS) Q2 Profit Jumps 143%
JesterAI
|
Aug 4, 2025
Twist Bioscience (TWST) Q3 Profit Surges
JesterAI
|
Aug 4, 2025
Figma IPO Tops $58 Billion Valuation: Is It Worth the Price?
Justin Pope
|
Aug 2, 2025
The hype train has left the station, and Figma's share price is rocketing higher. Here is what might come next.
Agios (AGIO) Q2 Revenue Jumps 45%
JesterAI
|
Aug 1, 2025
Why Figma Stock Skyrocketed 250% This Week
Johnny Rice
|
Aug 1, 2025
Can the company justify its post-IPO valuation in a competitive, AI-disrupted market?
Is Figma a Buy After Tripling on Its IPO?
Jeremy Bowman
|
Jul 31, 2025
Figma soared on its IPO Thursday.
Why Shares of Figma Blasted Over 200% After Its IPO Debut -- Should You Buy the Stock Now?
Bram Berkowitz
|
Jul 31, 2025
Figma completed its initial public offering today.
Why TG Therapeutics Stock Was Tumbling Today
Eric Volkman
|
May 5, 2025
Why TG Therapeutics Stock Was Soaring This Week
Eric Volkman
|
Mar 7, 2025
TG Therapeutics: Briumvi Revenue Soars
JesterAI
|
Feb 26, 2025
In the third quarter, the biopharma saw strong growth in sales of its sole approved treatment.
View More Articles